Severity of neuropsychological impairment in cocaine and alcohol addiction: association with metabolism in the prefrontal cortex - PubMed (original) (raw)
Severity of neuropsychological impairment in cocaine and alcohol addiction: association with metabolism in the prefrontal cortex
Rita Z Goldstein et al. Neuropsychologia. 2004.
Abstract
We used exploratory and confirmatory statistical approaches to study the severity of neuropsychological (NP) impairment in 42 crack/cocaine addicted subjects and in 112 comparison subjects (40 alcoholics and 72 controls). Twenty neuropsychological test indices most reliably defining predetermined cognitive domains were submitted to exploratory factor analysis. A four-dimensional model of neurocognitive function was derived: Verbal Knowledge, Visual Memory, Verbal Memory, and Attention/Executive functioning accounted for 63% of the variance. We then examined this model's association with resting glucose metabolism in the brain reward circuit measured with 2-deoxy-2[18F]fluoro-D-glucose positron emission tomography. Results revealed that (1) cocaine addicted individuals had a generalized mild level of neurocognitive impairment (<1 S.D. below control mean); and (2) controlling for age and education, relative metabolism in the dorsolateral prefrontal cortex significantly predicted the Visual Memory and Verbal Memory factors and relative metabolism in the anterior cingulate gyrus significantly predicted the Attention/Executive factor. Nevertheless, it remains to be determined whether metabolic changes in these regions are associated with addiction. Our results also suggest that compared to cocaine, alcohol has a more detrimental effect on Attention/Executive functioning, as assessed with traditional NP measures. We conclude that relative to other psychopathological disorders (such as schizophrenia), the severity of neuropsychological impairment in cocaine addiction is modest, albeit not indicative of the absence of neurocognitive dysfunction. The impact of such small differences in performance on quality of life, and possibly on craving and relapse, may be substantial. Tasks that simulate real-life decision-making or that target specific putative cognitive-behavioral or motivational-emotional mechanisms might offer greater sensitivity in characterizing the changes that accompany addiction to drugs. Obtaining valid estimates of alcohol use in cocaine addicted subjects is essential in characterizing neurocognitive functioning in individuals addicted to drugs.
Similar articles
- Regional brain metabolic response to lorazepam in alcoholics during early and late alcohol detoxification.
Volkow ND, Wang GJ, Overall JE, Hitzemann R, Fowler JS, Pappas N, Frecska E, Piscani K. Volkow ND, et al. Alcohol Clin Exp Res. 1997 Oct;21(7):1278-84. Alcohol Clin Exp Res. 1997. PMID: 9347090 Clinical Trial. - Neural correlates of hot and cold executive functions in polysubstance addiction: association between neuropsychological performance and resting brain metabolism as measured by positron emission tomography.
Moreno-López L, Stamatakis EA, Fernández-Serrano MJ, Gómez-Río M, Rodríguez-Fernández A, Pérez-García M, Verdejo-García A. Moreno-López L, et al. Psychiatry Res. 2012 Aug-Sep;203(2-3):214-21. doi: 10.1016/j.pscychresns.2012.01.006. Epub 2012 Sep 5. Psychiatry Res. 2012. PMID: 22959812 - Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction.
Volkow ND, Wang GJ, Fowler JS, Hitzemann R, Angrist B, Gatley SJ, Logan J, Ding YS, Pappas N. Volkow ND, et al. Am J Psychiatry. 1999 Jan;156(1):19-26. doi: 10.1176/ajp.156.1.19. Am J Psychiatry. 1999. PMID: 9892293 - [Structural and functional neuroanatomy of attention-deficit hyperactivity disorder (ADHD)].
Emond V, Joyal C, Poissant H. Emond V, et al. Encephale. 2009 Apr;35(2):107-14. doi: 10.1016/j.encep.2008.01.005. Epub 2008 Jul 7. Encephale. 2009. PMID: 19393378 Review. French. - The neuropsychiatry of chronic cocaine abuse.
Bolla KI, Cadet JL, London ED. Bolla KI, et al. J Neuropsychiatry Clin Neurosci. 1998 Summer;10(3):280-9. doi: 10.1176/jnp.10.3.280. J Neuropsychiatry Clin Neurosci. 1998. PMID: 9706535 Review.
Cited by
- Serotonin Transporter and Tryptophan Hydroxylase Gene Variations Mediate Working Memory Deficits of Cocaine Users.
Havranek MM, Vonmoos M, Müller CP, Büetiger JR, Tasiudi E, Hulka LM, Preller KH, Mössner R, Grünblatt E, Seifritz E, Quednow BB. Havranek MM, et al. Neuropsychopharmacology. 2015 Dec;40(13):2929-37. doi: 10.1038/npp.2015.146. Epub 2015 May 27. Neuropsychopharmacology. 2015. PMID: 26013962 Free PMC article. - Anosognosia for Memory Impairment in Addiction: Insights from Neuroimaging and Neuropsychological Assessment of Metamemory.
Le Berre AP, Sullivan EV. Le Berre AP, et al. Neuropsychol Rev. 2016 Dec;26(4):420-431. doi: 10.1007/s11065-016-9323-3. Epub 2016 Jul 22. Neuropsychol Rev. 2016. PMID: 27447979 Free PMC article. Review. - An Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future Research.
Norman LR, Basso M. Norman LR, et al. Curr Drug Abuse Rev. 2015;8(1):50-71. doi: 10.2174/1874473708666150309124820. Curr Drug Abuse Rev. 2015. PMID: 25751583 Free PMC article. Review. - The use of brain imaging to elucidate neural circuit changes in cocaine addiction.
Hanlon CA, Canterberry M. Hanlon CA, et al. Subst Abuse Rehabil. 2012 Sep;3(1):115-128. doi: 10.2147/SAR.S35153. Subst Abuse Rehabil. 2012. PMID: 23162375 Free PMC article. - Predictors of decision-making on the Iowa Gambling Task: independent effects of lifetime history of substance use disorders and performance on the Trail Making Test.
Barry D, Petry NM. Barry D, et al. Brain Cogn. 2008 Apr;66(3):243-52. doi: 10.1016/j.bandc.2007.09.001. Epub 2007 Oct 17. Brain Cogn. 2008. PMID: 17942206 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- 1K23 DA15517-01/DA/NIDA NIH HHS/United States
- K23 DA015517-02/DA/NIDA NIH HHS/United States
- R01 DA006891-10/DA/NIDA NIH HHS/United States
- K23 DA015517-01/DA/NIDA NIH HHS/United States
- R01 AA009481-06/AA/NIAAA NIH HHS/United States
- K23 DA015517-03/DA/NIDA NIH HHS/United States
- AA/ODO9481-04/AA/NIAAA NIH HHS/United States
- DA06891-06/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous